Mechanisms responsible for the failure of protamine to inactivate low-molecular-weight heparin

British Journal of Haematology

Volumn 116, Issue 1, 2002, Pages 178-186

  Crowther, Mark A ^a   Berry, Leslie R ^a   Monagle, Paul T ^b   Chan, Anthony K C ^a,c  

^a MCMASTER UNIVERSITY   (Canada)

^b ROYAL CHILDREN'S HOSPITAL   (Australia)

^c HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

Haemorrhage; Low molecular weight heparin; Neutralization; Protamine; Unfractionated heparin

Indexed keywords

DALTEPARIN; ENOXAPARIN; LOW MOLECULAR WEIGHT HEPARIN; NADROPARIN; PROTAMINE; REVIPARIN; TINZAPARIN;

ANIMAL TISSUE; ANTICOAGULATION; ARTICLE; CLINICAL PRACTICE; CONTROLLED STUDY; DENSITY; DRUG EFFECT; DRUG INACTIVATION; DRUG MECHANISM; FRACTIONATION; MOLECULAR WEIGHT; NONHUMAN; PRIORITY JOURNAL;

ANTICOAGULANTS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FACTOR XA; HEPARIN ANTAGONISTS; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; MOLECULAR WEIGHT; PROTAMINES; PROTHROMBIN; SULFATES;

EID: 0036159892     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2002.03233.x     Document Type: Article

References (32)

1. Molecular weight dependency of the heparin potentiated inhibition of thrombin and activated factor X: Effect of heparin neutralization in plasma
2. A microdetermination method for assaying glycosaminoglycans and proteoglycans
3. Protamine sulphate inhibits pentasaccharide (SR80027)-induced bleeding without affecting its antithrombotic and anti-factor Xa activity in the rat
4. Antagonism of SR 90107A/ORG 31540-induced bleeding by protamine sulfate in rats and mice
5. Micro-analysis and characterization of acidic glycosaminoglycans in human tissues
6. Low molecular weight protamine: A potential nontoxic heparin antagonist
7. A sensitive competitive binding assay for exogenous and endogenous heparins
8. Colorimetric method for determination of sugars and related substances
9. Inhibition of low molecular weight heparin by protamine chloride in vivo
10. The enzymatic degradation of heparin and heparitin sulfate. 3. Purification of a heparitinase and a heparinase from flavobacteria
11. Neutralization of heparan sulfate and low molecular weight heparin by protamine
12. An accurate colorimetric method for measurement of sulfaminohexose in heparins and heparan sulfates
13. A comparison of the strength of binding of antithrombin III, protamine and poly (L-lysine) to heparin samples of different anticoagulant activities
14. Low anticoagulant activity of high sulphated heparan sulphates
15. An improved method of sequential alcian blue and ammonical silver staining of chondroitin sulfate proteoglycan in polyacrylamide gels
16. Cleavage of structural proteins during the assembly of the head of bacteriophage T4
17. Structural studies on heparin. Tetrasaccharides obtained by heparinase degradation
18. Poor reversal of low molecular weight heparin by protamine
19. Partial reversal of low molecular weight heparin (PK10169) anti-Xa activity by protamine sulfate. In vitro and in vivo study during cardiac surgery with extracorporeal circulation
20. Antithrombotic effects of heparin oligosaccharides
21. Combined alcian blue and silver staining of sub-nanogram quantities of proteoglycans and glycosaminoglycans in sodium dodecyl-sulfate-polyacrylamide gels
22. Prenatal diagnosis of mucopolysaccharidosis by two-dimensional electrophoresis of amniotic fluid glycosaminoglycans
23. Molecular weight-dependent distribution of acidic glycosaminoglycans in human plasma
24. High-performance liquid chromatographic identification of disaccharides generated from heparan sulfate isomers using heparitinases
25. Electrostatic interactions in the heparin-enhanced reaction between human thrombin and antithrombin
26. Neutralization of the antithrombotic effects of heparin and fraxiparin by protamine sulfate
27. Reduced blood loss and transfusion requirements with low systemic heparinization: Preliminary clinical results in coronary artery revascularization
28. Method for determination of the sulfate content of glycosaminoglycans
29. Oligosaccharide mapping of heparan sulphate by polyacrylamide-gradient-gel electrophoresis and electrotransfer to nylon membrane
30. Qualitative and quantitative studies of heparin and chondroitin sulfates in normal human plasma
31. A [+18RGD] protamine variant for nontoxic and effective reversal of conventional heparin and low-molecular-weight heparin anticoagulation
32. Studies on the neutralizing effects of protamine on unfractionated and low molecular weight heparin (Fragmin) at the site of activation of the coagulation system in man